Please assess the completion status of the following clinical trial:

Trial Title: Efficacy of Calcifediol Supplementation in Asthma Control in Asthmatic Patients With Vitamin D Deficiency (ACViD)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Medical diagnosis of bronchial asthma~* serum 25(OH)D3 levels \< 30 ng/ml.~Exclusion Criteria:~* smoking habit ≥ 10 pack-years,~* taking vitamin D supplements,~* kidney disease (creat. \> 2 mg/dl),~* hypercalcaemia (corrected with proteins \> 10.5 mg/dl),~* repeat episodes of renal colic,~* any gastrointestinal disease that might interfere with vitamin D absorption,~* severe psychosocial problems,~* pregnant~* breast-feeding

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Intervention Group (IG) (Type: EXPERIMENTAL): Calcifediol (Hidroferol®) in 16,000-IU ampoules taken weekly by the oral route
- Control Group (CG) (Type: PLACEBO_COMPARATOR): Placebo in a presentation with an identical appearance taken weekly by the oral route

Based on this trial design, predict the completion outcome and termination type (if applicable).